Charles River Laboratories International, Inc.
278.35USD
-2.4100 (-0.86%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $2.95▼ | $3.04 | 1 | 9 |
| Next quarter | $3.31▲ | $3.24 | 9 | 1 |
| Current year | $11.32▲ | $11.09 | 12 | 1 |
| Next year | $12.69▲ | $12.31 | 13 | 1 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $2.74 | $3.02 | +0.28 (+10.3%) |
| 2026-03-31 | $1.95 | $2.06 | +0.11 (+5.4%) |
| 2025-12-31 | $2.35 | $2.39 | +0.04 (+1.9%) |
| 2025-09-30 | $2.34 | $2.43 | +0.09 (+3.9%) |
266 ratings from 34 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| TD Cowen | Maintained | Buy | $235 $300 | Aug 10, 2026 |
| Morgan Stanley | Maintained | Overweight | $260 $300 | Aug 7, 2026 |
| RBC Capital | Maintained | Outperform | $215 $282 | Aug 6, 2026 |
| Evercore ISI Group | Maintained | Outperform | $260 $300 | Aug 6, 2026 |
| JP Morgan | Upgraded from Neutral | Overweight | $180 $310 | Aug 6, 2026 |
| CLSA | Downgraded from Outperform | Hold | $219 | Jul 20, 2026 |
| Mizuho | Maintained | Neutral | $192 $230 | Jul 13, 2026 |
| Morgan Stanley | Maintained | Overweight | $220 $260 | Jul 9, 2026 |
| Morgan Stanley | Upgraded from Equal-Weight | Overweight | $185 $220 | Jun 17, 2026 |
| CLSA | Upgraded from Hold | Outperform | $167 $219 | May 29, 2026 |
| Barclays | Maintained | Overweight | $210 $220 | May 8, 2026 |
| Evercore ISI Group | Maintained | Outperform | $200 $220 | May 8, 2026 |
| Barclays | Maintained | Overweight | $200 $210 | Apr 14, 2026 |
| JP Morgan | Maintained | Neutral | $165 $160 | Apr 13, 2026 |
| UBS | Maintained | Neutral | $170 $175 | Feb 25, 2026 |
| TD Cowen | Maintained | Buy | $251 $235 | Feb 20, 2026 |
| Mizuho | Maintained | Neutral | $215 $175 | Feb 20, 2026 |
| Barclays | Maintained | Overweight | $215 $200 | Feb 19, 2026 |
| Evercore ISI Group | Maintained | Outperform | $260 $200 | Feb 19, 2026 |
| Citigroup | Maintained | Buy | $200 $265 | Jan 16, 2026 |
| Evercore ISI Group | Maintained | Outperform | $250 $260 | Jan 13, 2026 |
| Mizuho | Maintained | Neutral | $174 $200 | Dec 18, 2025 |
| Barclays | Maintained | Overweight | $210 $215 | Dec 15, 2025 |
| JP Morgan | Maintained | Neutral | $165 $190 | Dec 15, 2025 |
| Morgan Stanley | Maintained | Equal-Weight | $170 $185 | Nov 11, 2025 |
95 filings from 22 insiders · 35 buy / 10 sell over 6m
Officers and directors of CRL, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| FOSTER JAMES CDirector | Exercise | 33.6k | $194.12 | $6.69M | Aug 25, 2026 |
| FOSTER JAMES CDirector | Sell | 33.6k | $300.00 | $10.07M | Aug 25, 2026 |
| PARISOTTO SHANNON MOfficer | Exercise | 2.0k | $194.12 | $396k | Aug 19, 2026 |
| PARISOTTO SHANNON MOfficer | Sell | 2.0k | $294.12 | $600k | Aug 19, 2026 |
| GIRSHICK BIRGITChief Executive Officer | Gift | 528 | — | — | Aug 19, 2026 |
| ANDREWS NANCY CDirector | Exercise | 573 | $164.30 | $94k | Aug 18, 2026 |
| ANDREWS NANCY CDirector | Sell | 573 | $285.24 | $163k | Aug 18, 2026 |
| PARISOTTO SHANNON MOfficer | Sell | 3.7k | $279.66 | $1.04M | Aug 11, 2026 |
| GIRSHICK BIRGITChief Executive Officer | Sell | 6.5k | $279.90 | $1.82M | Aug 11, 2026 |
| GIRSHICK BIRGITChief Executive Officer | Exercise | 6.5k | $179.66 | $1.17M | Aug 11, 2026 |
| PARISOTTO SHANNON MOfficer | Exercise | 3.7k | $179.66 | $667k | Aug 11, 2026 |
| LAPLUME JOSEPH WOfficer | Gift | 257 | — | — | Aug 10, 2026 |
| FOSTER JAMES CDirector | Sell | 28.7k | $275.00 | $7.90M | Aug 10, 2026 |
| FOSTER JAMES CDirector | Exercise | 28.7k | $179.66 | $5.16M | Aug 10, 2026 |
| KNELL MICHAEL GUNNAROfficer | Sell | 6.6k | $258.53 | $1.73M | Aug 6, 2026 |
| CREAMER VICTORIA LOfficer | Sell | 4.2k | $259.16 | $1.08M | Aug 6, 2026 |
| KNELL MICHAEL GUNNAROfficer | Exercise | 2.3k | $179.66 | $460k | Aug 6, 2026 |
| CREAMER VICTORIA LOfficer | Exercise | 4.2k | $179.66 | $751k | Aug 6, 2026 |
| PARISOTTO SHANNON MOfficer | Sell | 5.0k | $263.00 | $1.33M | Aug 5, 2026 |
| FOSTER JAMES CDirector | Sell | 75.0k | $225.00 | $16.88M | Jun 29, 2026 |
No analyst notes on CRL yet.
Analyst Ratings
14 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 4 | 9 | 2 | 1 | 0 | Buy2.00 |
| 1 mo ago | 4 | 9 | 2 | 1 | 0 | Buy2.00 |
| 2 mo ago | 3 | 9 | 3 | 1 | 0 | Buy2.13 |
| 3 mo ago | 4 | 10 | 2 | 1 | 0 | Buy2.00 |